tirzepatide vs semaglutide chemical structure Tirzepatide, a New Era of Dual-Targeted Treatment for Diabetes and Obesity: A Mini-Review semaglutide vs tirzepatide weight loss
Description
Originally developed for type 2 diabetes, it has been FDA-approved for weight loss in overweight and obese individuals
The FDA-approved oral Wegovy (semaglutide 25 mg) is currently the only safe, proven oral GLP-1 for weight management
You do not want to explain your medication to a room of colleagues
Yes, tirzepatide causes diarrhea in a significant subset of patients
